Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA BRD9647 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.057 0.2
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.046 0.2
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA WP1130 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
Download CSV